Guest Post: Input Needed on the Naming of Biologic Drugs
Health Canada and the Institute for Safe Medication Practices Canada are seeking input from healthcare providers, consumers, and other interested and affected stakeholders on different approaches to the naming of biologic drugs, including biosimilars, in Canada.